Long term (current) drug therapy
Notes: Long term (current) use of birth control pill or patch ; Long term (current) use of apremilast ; Long term (current) use of immunomodulatory imide drug ; Long term (current) use of lenalidomide ; Long term (current) use of pomalidomide ; Long term (current) use of adalimumab ; Long term (current) use of etanercept ; Long term (current) use of infliximab ; Long term (current) use of monoclonal antibodies ; Long term (current) use of cyclosporine ; Long term (current) use of tacrolimus ; Long term (current) use of tofacitinib ; Long term (current) use of sirolimus ; Long term (current) use of azathioprine ; Long term (current) use omycophenolate ; Long term (current) use of purine synthesis (IMDH) inhibitors ; Long term (current) use of chlorambucil ; Long term (current) use of cisplatin ; Long term (current) use of cyclophosphamide ; Long term (current) use of 5-fluorouracil ; Long term (current) use of 6-mercaptopurine ; Long term (current) use of cytarabine ; Long term (current) use of methotrexate ; Long term (current) use of bleomycin ; Long term (current) use of doxorubicin ; Long term (current) use of mitomycin C ; Long term (current) use of paclitaxel ; Long term (current) use of plant alkaloids ; Long term (current) use of vinblastine ; Long term (current) use of vincristine ; Long term (current) use of etoposide ; Long term (current) use of irinotecan ; Long term (current) use of topotecan ; Long term (current) use of hydroxyurea ; Long term (current) use of raloxifene (Evista) ; Long term (current) use of tamoxifen (Nolvadex) ; Long term (current) use of toremifene (Fareston) ; Long term (current) use of anastrozole (Arimidex) ; Long term (current) use of exemestane (Aromasin) ; Long term (current) use of letrozole (Femara) ; Long term (current) use of estrogen receptor downregulators ; Long term (current) use of fulvestrant (Faslodex) ; Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist ; Long term (current) use of goserelin acetate (Zoladex) ; Long term (current) use of leuprolide acetate (leuprorelin) (Lupron) ; Long term (current) use of megestrol acetate (Megace) ; Long term (current) use of oral antidiabetic drugs ; Long term (current) use of methadone for pain management ; code, if applicable, to identify: ; estrogen receptor positive status (Z17.0) ; family history of breast cancer (Z80.3) ; genetic susceptibility to malignant neoplasm (cancer) (Z15.0-) ; personal history of breast cancer (Z85.3) ; personal history of prostate cancer (Z85.46) ; postmenopausal status (Z78.0) ; hormone replacement therapy (Z79.890) ; methodone use NOS (F11.9-) ; use of methodone for treatment of heroin addiction (F11.2-) ; drug abuse and dependence (F11-F19) ; drug use complicating pregnancy, childbirth, and the puerperium (O99.32-) ; long term (current) use of aspirin (Z79.82) ; long term (current) use of aspirin (Z79.82) ; long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85) ; long term (current) use of oral antidiabetic drugs (Z79.84) ; long term (current) use of oral hypoglycemic drugs (Z79.84) ; long term (current) use of steroids (Z79.5-) ; long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-) ; long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85) ; long term (current) use of insulin (Z79.4) ; long term (current) use of insulin (Z79.4) ; long term (current) use of oral hypoglycemic drugs (Z79.84) ; , if applicable: ; malignant neoplasm of breast (C50.-) ; malignant neoplasm of prostate (C61)